Support and Resistance Levels
Past performance
About Panacea Biotec Ltd Panacea Biotec Limited (PBL), established in 1984, is a leading research-based health management company in India, primarily recognized as the second largest vaccine producer in the country. With a strong product portfolio, PBL specializes in innovative prescription products across various therapeutic areas, including pain, diabetes, renal diseases, and vaccines. The company has advanced manufacturing facilities in Himachal Pradesh, Punjab, and Delhi, adhering to US-FDA, UK-MHRA, SAMCC, and WHO-cGMP standards, and holds 24 product patents worldwide.
PBL has a history of strategic collaborations with international organizations, enhancing its R&D capabilities. Significant milestones include partnerships with Chiron Vaccines (now Novartis) and the National Institute of Health, USA. In recent developments, PBL has restructured its operations, transferring its pharmaceutical formulations business to its subsidiary, Panacea Biotec Pharma Limited, and selling its pharmaceutical brands in India and Nepal to Mankind Pharma Limited. These strategic moves underscore PBL's focus on strengthening its core vaccine and health management offerings.